DK0950050T3 - Fremgangsmåde til krystallisering af et tetrahydropyridinderivat og resulterende krystalliske former - Google Patents

Fremgangsmåde til krystallisering af et tetrahydropyridinderivat og resulterende krystalliske former

Info

Publication number
DK0950050T3
DK0950050T3 DK97952986T DK97952986T DK0950050T3 DK 0950050 T3 DK0950050 T3 DK 0950050T3 DK 97952986 T DK97952986 T DK 97952986T DK 97952986 T DK97952986 T DK 97952986T DK 0950050 T3 DK0950050 T3 DK 0950050T3
Authority
DK
Denmark
Prior art keywords
crystallizing
crystalline forms
resulting crystalline
tetrahydropyridine derivative
tetrahydropyridine
Prior art date
Application number
DK97952986T
Other languages
Danish (da)
English (en)
Inventor
Antoine Caron
Bruno Franc
Olivier Monnier
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Application granted granted Critical
Publication of DK0950050T3 publication Critical patent/DK0950050T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK97952986T 1996-12-23 1997-12-23 Fremgangsmåde til krystallisering af et tetrahydropyridinderivat og resulterende krystalliske former DK0950050T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9615904A FR2757543B1 (fr) 1996-12-23 1996-12-23 Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues

Publications (1)

Publication Number Publication Date
DK0950050T3 true DK0950050T3 (da) 2006-01-23

Family

ID=9499043

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97952986T DK0950050T3 (da) 1996-12-23 1997-12-23 Fremgangsmåde til krystallisering af et tetrahydropyridinderivat og resulterende krystalliske former

Country Status (38)

Country Link
EP (1) EP0950050B1 (enrdf_load_stackoverflow)
JP (2) JP4499188B2 (enrdf_load_stackoverflow)
KR (1) KR100586670B1 (enrdf_load_stackoverflow)
CN (1) CN1129580C (enrdf_load_stackoverflow)
AR (1) AR009672A1 (enrdf_load_stackoverflow)
AT (1) ATE307802T1 (enrdf_load_stackoverflow)
AU (1) AU736697B2 (enrdf_load_stackoverflow)
BR (1) BR9714081A (enrdf_load_stackoverflow)
CA (1) CA2275596C (enrdf_load_stackoverflow)
CO (1) CO5070688A1 (enrdf_load_stackoverflow)
CZ (1) CZ296689B6 (enrdf_load_stackoverflow)
DE (1) DE69734460T2 (enrdf_load_stackoverflow)
DK (1) DK0950050T3 (enrdf_load_stackoverflow)
DZ (1) DZ2383A1 (enrdf_load_stackoverflow)
EE (1) EE04188B1 (enrdf_load_stackoverflow)
EG (1) EG21567A (enrdf_load_stackoverflow)
ES (1) ES2251038T3 (enrdf_load_stackoverflow)
FR (1) FR2757543B1 (enrdf_load_stackoverflow)
HR (1) HRP970699B1 (enrdf_load_stackoverflow)
HU (1) HU227425B1 (enrdf_load_stackoverflow)
IL (1) IL129938A (enrdf_load_stackoverflow)
IN (1) IN186976B (enrdf_load_stackoverflow)
IS (1) IS2357B (enrdf_load_stackoverflow)
MY (1) MY118015A (enrdf_load_stackoverflow)
NO (1) NO312364B1 (enrdf_load_stackoverflow)
NZ (1) NZ336130A (enrdf_load_stackoverflow)
PL (1) PL190494B1 (enrdf_load_stackoverflow)
RS (1) RS49882B (enrdf_load_stackoverflow)
RU (1) RU2192416C2 (enrdf_load_stackoverflow)
SA (1) SA98180971B1 (enrdf_load_stackoverflow)
SI (1) SI0950050T1 (enrdf_load_stackoverflow)
SK (1) SK285088B6 (enrdf_load_stackoverflow)
TR (1) TR199901363T2 (enrdf_load_stackoverflow)
TW (1) TW518322B (enrdf_load_stackoverflow)
UA (1) UA60324C2 (enrdf_load_stackoverflow)
UY (1) UY24825A1 (enrdf_load_stackoverflow)
WO (1) WO1998028271A1 (enrdf_load_stackoverflow)
ZA (1) ZA9711576B (enrdf_load_stackoverflow)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2757543B1 (fr) * 1996-12-23 1999-04-02 Sanofi Sa Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues
FR2782082B3 (fr) * 1998-08-05 2000-09-22 Sanofi Sa Formes cristallines de (r)-(+)-n-[[3-[1-benzoyl-3-(3,4- dichlorophenyl)piperidin-3-yl]prop-1-yl]-4-phenylpiperidin-4 -yl]-n-methylacetamide (osanetant) et procede pour la preparation dudit compose
JP5605862B2 (ja) 2010-03-12 2014-10-15 株式会社日本触媒 吸水性樹脂の製造方法
WO2012143937A2 (en) * 2011-04-15 2012-10-26 Emcure Pharmaceuticals Limited An improved rilpivirine process

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531707A1 (fr) * 1982-08-16 1984-02-17 Midy Spa Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques
FR2757543B1 (fr) * 1996-12-23 1999-04-02 Sanofi Sa Procede pour la cristallisation d'un derive de tetrahydropyridine et formes cristallines ainsi obtenues

Also Published As

Publication number Publication date
MY118015A (en) 2004-08-30
EP0950050B1 (fr) 2005-10-26
IN186976B (enrdf_load_stackoverflow) 2001-12-22
IS2357B (is) 2008-04-15
CA2275596C (en) 2005-10-11
YU28999A (sh) 2003-01-31
RS49882B (sr) 2008-08-07
UA60324C2 (uk) 2003-10-15
SI0950050T1 (sl) 2006-04-30
HK1024002A1 (en) 2000-09-29
FR2757543A1 (fr) 1998-06-26
ES2251038T3 (es) 2006-04-16
BR9714081A (pt) 2000-05-09
ZA9711576B (en) 1998-06-25
NO993076D0 (no) 1999-06-22
CZ296689B6 (cs) 2006-05-17
KR20000069504A (ko) 2000-11-25
HUP0001387A3 (en) 2002-03-28
AU736697B2 (en) 2001-08-02
IL129938A0 (en) 2000-02-29
CZ229299A3 (cs) 1999-09-15
SA98180971B1 (ar) 2006-09-13
CO5070688A1 (es) 2001-08-28
JP2009197022A (ja) 2009-09-03
CN1129580C (zh) 2003-12-03
TW518322B (en) 2003-01-21
PL334256A1 (en) 2000-02-14
EP0950050A1 (fr) 1999-10-20
DZ2383A1 (fr) 2002-12-28
HU227425B1 (en) 2011-05-30
PL190494B1 (pl) 2005-12-30
NO312364B1 (no) 2002-04-29
JP4499188B2 (ja) 2010-07-07
CA2275596A1 (en) 1998-07-02
JP2001507012A (ja) 2001-05-29
HRP970699B1 (en) 2007-03-31
AR009672A1 (es) 2000-04-26
DE69734460T2 (de) 2006-07-06
EG21567A (en) 2001-12-31
ATE307802T1 (de) 2005-11-15
FR2757543B1 (fr) 1999-04-02
AU5668498A (en) 1998-07-17
NZ336130A (en) 2001-01-26
RU2192416C2 (ru) 2002-11-10
SK285088B6 (sk) 2006-06-01
SK82899A3 (en) 1999-12-10
EE9900264A (et) 2000-02-15
CN1241180A (zh) 2000-01-12
HRP970699A2 (en) 1998-10-31
IS5076A (is) 1999-06-10
IL129938A (en) 2004-06-20
TR199901363T2 (xx) 1999-08-23
HUP0001387A2 (hu) 2000-09-28
EE04188B1 (et) 2003-12-15
KR100586670B1 (ko) 2006-06-07
NO993076L (no) 1999-06-22
DE69734460D1 (de) 2005-12-01
WO1998028271A1 (fr) 1998-07-02
UY24825A1 (es) 1998-04-21

Similar Documents

Publication Publication Date Title
DK0973796T3 (da) Fremgangsmåde til fremstilling og oprensning af et N-alkyleret aspartamderivat
DK0845956T4 (da) Fremgangsmåde til fremstilling af en tandbörste
FI965093A7 (fi) Laite ja menetelmä kellon säätämiseksi ja kytkemiseksi
DK0740052T3 (da) Fremgangsmåde og anlæg til implementering af en termodynamisk cyklus
NO993006D0 (no) FremgangsmÕte for separering av paraxylen omfattende et adsorpsjonstrinn med injeksjon av vann og et krystallisasjonstrinn
FI941866L (fi) Menetelmä liuoksen fraktioimiseksi
DK121796A (da) Fremgangsmåde og anlæg til fjernelse af en overbygning
DK139093A (da) Køleanlæg og fremgangsmåde til styring af et køleanlæg
DE69620107D1 (de) Kristallisationsverfahren
DK0946312T3 (da) Fremgangsmåde til automatiseret processtyring af en udretningsproces
DK0900253T3 (da) Bitumensammensætninger og en fremgangsmåde til deres fremstilling
EE9600153A (et) Meetod nikotiinhappeamiidi saamiseks
NO995909L (no) Krystallinske makrolider og fremgangsmåte for deres fremstilling
DK0734382T3 (da) Krystallinske N-acetyl-neuraminsyrederivater og fremgangsmåder til deres fremstilling
DK0824517T3 (da) Fremgangsmåde til fremstilling af lercanidipinhydrochlorid
DK0625586T3 (da) Konstruktionselement og fremgangsmåde til fremstilling af dette
DK0711774T3 (da) Nye krystallinske cephem-syreadditionssalte og fremgangsmåder til deres fremstilling
DK0950050T3 (da) Fremgangsmåde til krystallisering af et tetrahydropyridinderivat og resulterende krystalliske former
FI942288L (fi) Menetelmä sulakkeen valmistamiseksi
DK0698337T3 (da) Fremgangsmåde til adskillelse af markafgrøder og iblandinger
DK0789700T3 (da) Forbedret fremgangsmåde til fremstilling af et D-(+)-biotin-mellemprodukt
FI971675A0 (fi) Menetelmä bradykiniinin liittyvien tilojen inhiboimiseksi
MD254B1 (ro) Procedeu de cultivare a marului
FI961942A7 (fi) Menetelmä jätteiden inertoimiseksi kiteyttämällä
DK153497A (da) Fremgangsmåde til fremstilling af tagværkselementer og midler til udøvelse af fremgangsmåden